Answers are grounded in this paper and cite their sources.
This invited editorial refers to ‘Endotype-informed therapy and effects on illness perception and psychological health in patients with chest pain and no obstructive coronary artery disease’ by C.P. Bradley et al., https://doi.org/10.1093/ehjqcco/qcag081. In the contemporary era, ischaemic heart disease is classified as epicardial (including atherosclerotic disease and vasospastic disease) or microvascular pathology. Data from large registries suggest that at least two out of five patients undergoing a coronary angiogram for angina do not have epicardial atherosclerotic disease.1 Presence of angina with non-obstructive coronary artery disease (ANOCA) has been extensively validated as a risk marker for adverse cardiovascular events in several large observational cohorts, such as Women's Ischemia Syndrome Evaluationand cardiac positron emission tomography (PET) registries.2 Despite growing attention to ANOCA as a distinct entity, diagnosing this condition in real-world practice remains elusive. In this issue of the EHJ QCCO, Bradley et al.3 present a pre-specified analysis of the CorCMR trial examining the impact of appropriately diagnosing ANOCA with non-invasive endotyping on patients’ illness perception, anxiety, and depression. The CorCMR trial was a prospective superiority trial comprising 250 ANOCA patients who underwent an initial coronary angiogram, followed by a stress cardiac magentic resonance imaging (CMR) with pixel mapping derived myocardial blood flow quantification at rest and during adenosine stress. Subjects were randomized to CMR endotype–informed care vs. routine care informed by history, coronary angiogram, and any prior non-invasive imaging. The initial diagnostic endotype was decided by the procedural cardiologist and categorized as obstructive disease, microvascular angina, vasospastic angina, or non-cardiac chest pain. In the CMR group, the initially assigned endotype was revised with CMR data. The previously published primary analyses demonstrated that 53% patients randomized to CMR based care were reclassified to microvascular angina from non-cardiac chest pain with improvements in the Seattle Angina Questionnaire scores. This additional study by Bradley et al. extends these findings to show that appropriate endotype-linked care guided by CMR in ANOCA patients was associated with significant and sustained improvements in illness perception and psychological health with lesser depression and anxiety at up to 12 months post-randomization. At 6 and 12 months, the adjusted mean difference in the Brief Illness Perception Questionnaire scores were −8.7 (95% CI −12.0, −5.3) and −10.8 (95% CI −14.3, −7.3), and in the Patient Health Questionnaire-4 (PHQ4) scores measuring psychological health were −0.88 (95% CI −1.2, −0.6) and −1.00 (95% CI 1.3, −0.6), respectively. There was no significant interaction by age or sex, but a statistically significant inverse interaction benefit was noted by deprivation status.
No takes yet. Share an insight, caveat, or question.
Shore et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: